These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29268637)

  • 1. The pharmacological treatment of bronchiectasis.
    Melani AS; Lanzarone N; Rottoli P
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):245-258. PubMed ID: 29268637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ; Soler Cataluña JJ; Serra PC
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational inhaled therapies for non-CF bronchiectasis.
    Antoniu SA
    Expert Opin Investig Drugs; 2018 Feb; 27(2):139-146. PubMed ID: 29338445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis.
    Cartlidge MK; Hill AT
    Expert Opin Investig Drugs; 2017 Sep; 26(9):1091-1097. PubMed ID: 28778139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
    Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME
    Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.
    Xu MJ; Dai B
    Ther Adv Respir Dis; 2020; 14():1753466620936866. PubMed ID: 32615859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
    Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
    Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
    Tay GT; Reid DW; Bell SC
    Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
    Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital.
    Altenburg J; Wortel K; van der Werf TS; Boersma WG
    Neth J Med; 2015 May; 73(4):147-54. PubMed ID: 25968285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis.
    Amaro R; Panagiotaraka M; Alcaraz V; Torres A
    Expert Rev Respir Med; 2018 Aug; 12(8):683-691. PubMed ID: 30010445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.
    Sugianto TD; Chan HK
    Expert Opin Drug Deliv; 2016; 13(1):7-22. PubMed ID: 26289675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.
    Goldman N; Loebinger MR; Wilson R
    Expert Rev Respir Med; 2016 Dec; 10(12):1259-1268. PubMed ID: 27820964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic options for noncystic fibrosis bronchiectasis.
    Yap VL; Metersky ML
    Curr Opin Infect Dis; 2015 Apr; 28(2):171-6. PubMed ID: 25692269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.